Page 3 of lupin

There is a significant Indian population affected with diabetes for both Type 1 and Type 2 Diabetes Mellitus, where Insulin…

An estimated 80 million people above the age of 18 years have diabetes in India, in addition to 25 million…

The drug is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2…

This launch builds on the proven success of Humrahi, which has been instrumental in guiding patients toward better diabetes management,…

Bumetanide Injection USP (RLD Bumex) had an estimated annual sale of USD 20 million in the U.S, as per IQVIA…

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, extroamphetamine Sulfate, and Amphetamine Sulfate Extended-Release Capsules (RLD Adderall XR) had estimated annual sales of…

Raltegravir Tablets USP, 600 mg (RLD Isentress HD) had an estimated annual sale of USD 36 million in the U.S.…

According to the World Health Organization (WHO), it is the second leading cause of death and the third leading cause…

In the respiratory category, Lupin’s strategy includes the inhalation portfolio with accelerated development of pipeline products and green propellant development…

Claus joins Lupin from Takeda Pharmaceuticals, where he led the Global Strategy for Rare Diseases.

Pred Forte had estimated annual sales of USD 198 million in the U.S., as per IQVIA MAT August 2024.

This acquisition will enable Lupin gain access to MNI’s wide portfolio of nine brands, that are marketed as branded products…

This product will be manufactured at Lupin’s Pithampur facility in India.